Lumentum Holdings Inc. — Form 10-Q Summary
Business context and reporting period
Fiscal first quarter 2016, the three months ended September 26, 2015; comparable period ended September 27, 2014. Lumentum supplies optical and photonic products through Optical Communications (OpComms) and Lasers segments. It became an independent public company on August 1, 2015, following its separation from Viavi (formerly JDSU). Pre-separation results reflect allocations from Viavi and may not be directly comparable with standalone costs.
Key financial metrics
| Metric | Q1 FY2016 | Prior comparable quarter |
|---|---|---|
| Revenue | $212.6 million | $219.0 million |
| Gross profit / margin | $66.9 million / 31.5% | $70.3 million / 32.1% |
| Operating income (loss) | ($2.5) million | $5.2 million |
| Net income (loss) | ($0.2) million | $4.3 million |
| Net income (loss) attributable to common shareholders | ($10.0) million; ($0.17) per share | $4.3 million; $0.07 per share |
| Operating cash flow | $10.6 million | $0.4 million |
| Capital expenditures | $13.9 million | $13.8 million |
- Revenue was nearly flat in OpComms (about $177 million) and declined 15.4% in Lasers to $35.5 million. OpComms gross margin rose to 31.4%; Lasers gross margin fell to 39.9% from 50.6%.
- SG&A rose $5.7 million, or 20.1%, mainly due to $5.1 million of Viavi separation-related costs. R&D expense was $34.4 million, down 1.7%.
- The common-shareholder loss includes $9.7 million of preferred-stock accretion and $0.1 million of preferred dividends. Consolidated net loss was $0.2 million; a $2.2 million unrealized derivative gain partly offset operating and other losses.
- Cash and cash equivalents were $142.1 million at quarter-end, up from $14.5 million at June 27, primarily reflecting $132.9 million of net transfers from Viavi. Current assets were $453.7 million and current liabilities $132.6 million. The balance sheet reports no borrowings; Viavi debt was not attributed to Lumentum.
- Total liabilities were $148.9 million. Purchase obligations totaled $151.8 million, most expected within one year; operating lease obligations totaled $24.9 million.
Changes, outlook, risks and unusual items
- Revenue declined 2.9%, primarily because of lower Lasers sales, particularly solid-state lasers amid weaker market demand. Datacom growth partly offset lower Telecom and Consumer and Industrial revenue.
- Management expected R&D spending to increase in absolute dollars in future quarters and planned to reduce SG&A as a share of revenue. It provided no quantified revenue or earnings guidance and cautioned that results may vary.
- Management said cash on hand and expected operating cash flows should cover liquidity and capital-spending needs for at least 12 months. This assessment is subject to working-capital, demand, supplier, currency, investment and other risks.
- Amada acquired $35.8 million of redeemable convertible Series A preferred stock in Lumentum’s subsidiary. It carries cumulative dividends at 2.5% annually, may be convertible beginning after two years, and is redeemable by the holder beginning after five years. The preferred stock is presented as mezzanine equity.
- Key disclosed risks include customer concentration (the five largest customers represented over 48% of quarterly revenue), pricing pressure and competition, reliance on limited suppliers and contract manufacturers, product quality and yield, and international and foreign-exchange exposure. A 10% currency-rate movement was estimated to change local-currency expenses by $1.4 million for the quarter.
- The company reported ordinary-course legal claims without identifying a specific material proceeding; it said an unfavorable outcome could nevertheless materially affect results. It also disclosed environmental exposure and separation-related tax, indemnification and execution risks.
- Foreign-currency translation reduced comprehensive income by $5.5 million. Inventory write-offs were $0.5 million, and $0.9 million of restructuring expense related to workforce changes, including retention costs.
Important facts for investors to verify
- Reconcile the filing’s liquidity discussion, which cites cash of $142.6 million in one passage, with the balance sheet and cash-flow statement amounts of $142.1 million.
- Check the segment revenue figures: the notes report OpComms revenue of $177.1 million, while the MD&A table lists $177.0 million; Lasers revenue is reported as $35.5 million in the segment note and $35.6 million in the MD&A table.
- Assess whether lower Lasers demand and margin pressure continue, and whether OpComms growth and margin improvements persist.
- Review the terms, accretion, dividend obligations, conversion and redemption effects of the Series A preferred stock on common shareholders.
- Monitor the $151.8 million of purchase obligations, customer concentration, supplier exposure, and the effect of operating independently from Viavi on costs and cash generation.
- Evaluate the risks associated with tax valuation allowances, the separation’s tax treatment and indemnities, and the planned international operating structure.